← k3vl4r
Log inGet started →

MBRX (Moleculin Biotech Inc) Price Forecast

AI-generated price forecast for Moleculin Biotech Inc (MBRX) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's calibrated AI forecast currently reads MBRX as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 0.4201. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

0.4201

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

MBRX forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-80.49%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called MBRX's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest MBRX news

From the market-news feed the forecasts are read against.

  • Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit · Yahoo · Oct 7
  • 8-K Material Event Tue Sep 29 2026 · ldr:last10k.com · Sep 29
  • Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout · Yahoo · Sep 29
  • Moleculin Biotech Completes Patient Enrollment In Part A Of Its Pivotal Phase 2/3 MIRACLE Study Of Annamycin In Combination With Cytarabine To Treat Adults With Relapsed Or Refractory Acute Myeloid Leukemia · Benzinga · Sep 29
  • Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine · Yahoo · Sep 28

🔒

See the full MBRX forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

MBRX forecast — frequently asked

Will MBRX go up?

K3vl4r's calibrated AI forecast currently reads MBRX as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the MBRX price prediction for 2026?

K3vl4r's model projects MBRX toward $0.0844 over the next ~4 weeks, a -80.5% move from $0.4326. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

MMSIOTLKABUSMLSSCGEMPDSBJANXADCTINSMARQTEBSINMBSEERSGRY

Will MBRX reach…?

Will MBRX reach $0.5000?Will MBRX reach $1.00?Will MBRX reach $2.00?Will MBRX reach $3.00?

Or see the full MBRX price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare MBRX

MBRX vs MMSIMBRX vs OTLKMBRX vs ABUSMBRX vs MLSSMBRX vs CGEMMBRX vs PDSB

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.